From CPIPS you will have opportunity to：
1: Following the latest development of China Patent Law Amendment, Patent Linkage, Patent Term Extension reform , and related Drug Regulatory Updates in China.
2: Addressing Challenges and Uncertainties under Brexit, Unitary Patent & UPC in Europe.
3: Understanding the differences and updated requirements of examination standards, patent invalidation, patent litigation in China, US, EU, Japan and other region.
4: Learning IP management and practical experiences from Global and China leading pharma companies.
5: Meeting your clients/partners face to face and interact with industry peers.
